X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Lancet Diabetes & Endocrinology

期刊標題檢索 LANCET DIABETES 最新評論: I originally wanted to test the waters, but it's been 6 days and the s... (2024-06-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Lancet Diabetes & Endocrinology]您好,您是該頁面的第 25674 位訪客。

期刊簡介
期刊名稱Lancet Diabetes & Endocrinology Lancet Diabetes & Endocrinology
LetPub Score
9.3
50 ratings
Rate

Reputation
10.0

Influence
9.3

Speed
6.9

期刊簡稱LANCET DIABETES ENDO
ISSN2213-8587
E-ISSN2213-8595
h-index77
CiteScore
CiteScoreSJRSNIPCiteScore Rank
61.5010.2479.029
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q11 / 244
Category: Medicine
Subcategory: Internal Medicine
Q11 / 167
Category: Medicine
Subcategory: Endocrinology
Q11 / 128

自引率 (2023-2024)1.60%自引率趨勢
掲載範囲
Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
官方網站http://www.thelancet.com/journals/landia/onlinefirst
在線稿件提交https://www.editorialmanager.com/THELANCETDE
開放訪問No
出版商Elsevier BV
主題領域ENDOCRINOLOGY & METABOLISM
出版國/地區ENGLAND
發行頻率
創刊年0
每年文章數57每年文章數趨勢
黃金OA百分比17.82%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ11/186
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2213-8587%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Lancet Diabetes & Endocrinology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645714
    BIOMATERIALS601310
    Frontiers in Pharmacology503575
    BIOMEDICINE & PHARMACOTHERAPY498661
    JOURNAL OF ETHNOPHARMACOLOGY496048
    Journal of Materials Chemistry B476181
    Frontiers in Immunology461422
    COMPUTERS IN BIOLOGY AND MEDICINE420660
    COLLOIDS AND SURFACES B-BIOINTERFACES419544
    Frontiers in Oncology415881
  •  

    Lancet Diabetes & Endocrinology Lancet Diabetes & Endocrinology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Lancet Diabetes & Endocrinology] 的評論撰寫評論
作者: SereinCao


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-25 14:31:45 評論於
I originally wanted to test the waters, but it's been 6 days and the status is still Submitted to journal... I've submitted to many journals before and it has never been this slow. I might have to wait another two weeks before emailing to inquire about the situation.
(0) 讚! | SereinCao

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Lancet Diabetes & Endocrinology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*